EUVIMEDEUVIMED entdecken
Leserbrief

Comment on “Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early‐Grade Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial”

Bodhisatwa Choudhuri iD

International Journal of Rheumatic Diseases · 2026-11 · 29 (11)

DOI: 10.1111/1756-185x.70942 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 28.10.2026. Verfasst von Bodhisatwa Choudhuri. Beteiligte Einrichtung: Department of Critical Care, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Critical Care, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.
  • Department of Critical Care, Emergency Medicine & Rheumatology, Parkview Super-Specialty Hospital, Kolkata, West Bengal, India.

ORCID-Profile: Bodhisatwa Choudhuri

Zitieren

APA

Choudhuri, B. (2026). Comment on “Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early‐Grade Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial”. International Journal of Rheumatic Diseases, 29(11). https://doi.org/10.1111/1756-185x.70942

Vancouver

Choudhuri B. Comment on “Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early‐Grade Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial”. International Journal of Rheumatic Diseases. 2026;29(11). doi:10.1111/1756-185x.70942

BibTeX
@article{Choudhuri2026,
  author = {Choudhuri, Bodhisatwa},
  title = {Comment on “Efficacy and Safety of Tofacitinib Versus Placebo in Patients With Early‐Grade Knee Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial”},
  journal = {International Journal of Rheumatic Diseases},
  year = {2026},
  volume = {29},
  number = {11},
  doi = {10.1111/1756-185x.70942}
}
Kostenlos starten →